<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Immune-based cancer treatment</title>
    <subTitle>the T lymphocyte response</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Alexander, Michael A. (Michael Allen)</namePart>
    <namePart type="date">1953-</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="lcsh">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nhu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Enfield, N.H</placeTerm>
    </place>
    <publisher>Science Publishers</publisher>
    <dateIssued>c2011</dateIssued>
    <dateIssued encoding="marc">2011</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <form authority="gmd">electronic resource</form>
    <internetMediaType>application/PDF</internetMediaType>
    <extent>xv, 235 p.</extent>
  </physicalDescription>
  <tableOfContents>1. Which cells control the anti-cancer T cell immune response? -- 2. Antigen presentation -- 3. T cells and cancer cells : components of immune-based anti-cancer therapy -- 4. Anti-cancer vaccines : new approaches -- 5. How and why do we get cancer and can immune-based anti-cancer therapy save us? -- 6. Immunotherapeutic approaches to the treatment of leukemia -- 7. Cancer-induced autoimmunity -- 8. Can we solve the cancer stem cell program and cure cancer using T cell-based immunotherapy? -- 9. Translational immunology and its impact on anti-cancer T cell immunity and the development of immunotherapeutic treatments for cancer -- 10. Dendritic cells, immunotherapy and the anti-cancer T cell response -- 11. Regulatory T cells, dendritic cells and the success of immunotherapeutic treatments for cancer -- 12. NK cells and their role in the development of immune-based anti-cancer therapy -- 13. How cancer cells influence the anti-cancer T cell immune response and why this is a problem during the immunotherapeutic treatment of cancer -- 14. The T cell anti-cancer response, T cell regulation, and immunotherapy of neural crest cancers -- 15. The immunological hole : will we fall in? -- 16. Summary and concluding remarks.</tableOfContents>
  <note type="statement of responsibility">Michael A. Alexander.</note>
  <note>Includes bibliographical references (p. [217]-232) and index.</note>
  <note>Also available in print edition.</note>
  <note>Mode of access: World Wide Web.</note>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Immunological aspects</topic>
  </subject>
  <subject authority="lcsh">
    <topic>T cells</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Immunotherapy</topic>
  </subject>
  <relatedItem type="otherFormat"/>
  <identifier type="isbn">9781439861837 (ebook : PDF)</identifier>
  <identifier type="uri">http://marc.crcnetbase.com/isbn/9781439861837</identifier>
  <location>
    <url>http://marc.crcnetbase.com/isbn/9781439861837</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">FlBoTFG</recordContentSource>
    <recordCreationDate encoding="marc">110413</recordCreationDate>
    <recordChangeDate encoding="iso8601">20171224123758.0</recordChangeDate>
    <recordIdentifier source="FlBoTFG">SCP0NE10521PDF</recordIdentifier>
  </recordInfo>
</mods>
